A. Alip

发表

Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice.

W. Z. Wan Ishak, A. Bustam, M. Saad, 2015, Asian Pacific journal of cancer prevention : APJCP.

Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.

M. See, V. Subrayan, A. Alip, 2018, Breast.

Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.

L. Tho, H. Chandran, M. Saad, 2015, Asian Pacific journal of cancer prevention : APJCP.

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017

M. M. Abdullah, A. Razack, Jasmine Lim, 2019, BJU international.

Single vs multiple fraction palliative radiotherapy for uncomplicated painful bone metastases treated at University of Malaya Medical Centre: A single institutional Malaysian experience

M. Saad, A. Alip, Ina Shaliny Duraisamy, 2018, Aging medicine (Milton (N.S.W)).

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.

T. Mitsudomi, S. Peters, D. Planchard, 2019, Annals of Oncology.

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort

Jasmine Lim, M. Saad, Ann Kavitha Mathew, 2020, Cancer medicine.

Barriers of and strategies for shared decision‐making implementation in the care of metastatic breast cancer: A qualitative study among patients and healthcare professionals in an Asian country

S. Teo, P. Lee, C. Ng, 2022, Health expectations : an international journal of public participation in health care and health policy.

Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010.

W. Z. Wan Ishak, M. Yusof, V. Phua, 2015, Asian Pacific journal of cancer prevention : APJCP.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

S. Peters, S. Senan, D. Tan, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

T. Mitsudomi, S. Peters, D. Planchard, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

N. Hoa, F. Schutz, E. Sirachainan, 2021, Therapeutic advances in medical oncology.

Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

P. Cheah, C. Liam, Y. Pang, 2020, Cancer management and research.

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

M. M. Abdullah, S. How, C. Liam, 2019, BMC Cancer.

Practical updates in medical therapy for advanced and metastatic renal cell carcinoma

R. Rajandram, M. Saad, T. Ong, 2018 .

Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country.

N. Taib, M. See, M. Saad, 2014, Asian Pacific journal of cancer prevention : APJCP.

1023 Prostate cancer in multi-ethnic Asian men

N. Bhoo-Pathy, A. Razack, Jasmine Lim, 2015 .

Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib

C. Liam, Y. Pang, G. Ho, 2019, Annals of Oncology.

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

M. M. Abdullah, S. How, C. Liam, 2019, BMC Cancer.

Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country

F. Azizi, C. Ng, M. N. Nor Afiah, 2020, Journal of Cancer Education.

Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country

P. Lee, C. Ng, M. N. Nor Afiah, 2020, Journal of Cancer Education.

Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience

M. Saad, T. Ong, N. Yap, 2018, Journal of cancer research and therapeutics.

Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.

M. See, V. Subrayan, A. Alip, 2018, Breast.

Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience

M. Saad, T. Ong, N. Yap, 2018, Journal of cancer research and therapeutics.

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study

A. Bustam, M. Saad, A. Alip, 2024, medRxiv.